SCHEMBL7603776

SCHEMBL7603776

Cc1cc2c(-c3ccccc3)c3cc(C)c(C)cc3c(-c3ccc(-n4c5ccccc5c5ccccc54)cc3)c2cc1C

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.53
KDM4E B2RXH2 1/20 0.53
ATM Q13315 1/20 0.53
KMT2A Q03164 3/20 0.44
MYC P01106 1/20 0.41
HDAC4 P56524 1/20 0.40
IL1R1 P14778 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
MEN1 O00255 1/20 0.37
ALDH1A1 P00352 1/20 0.37
MAPT P10636 1/20 0.37
HTT P42858 1/20 0.37
RORC P51449 1/20 0.36
AKR1C4 P17516 1/20 0.36
AKR1C3 P42330 1/20 0.36
AKR1C2 P52895 1/20 0.36
AKR1C1 Q04828 1/20 0.36
PLA2G2A P14555 1/20 0.36
ACHE P22303 1/20 0.36
AVPR1A P37288 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13433011 0.93 KDM4E (0.46) L3MBTL1KDM4EATMKMT2AMYC
SCHEMBL9890947 0.92 KDM4E (0.47) L3MBTL1KDM4EATMKMT2AHDAC4
SCHEMBL9890946 0.91 KDM4E (0.46) L3MBTL1KDM4EATMKMT2AHDAC4
SCHEMBL13433022 0.90 KDM4E (0.44) L3MBTL1KDM4EATMKMT2AMYC
SCHEMBL13761759 0.90 KDM4E (0.50) L3MBTL1KDM4EATMKMT2AMYC
SCHEMBL13761768 0.90 KDM4E (0.50) L3MBTL1KDM4EATMKMT2AMYC
SCHEMBL13761766 0.90 KDM4E (0.50) L3MBTL1KDM4EATMKMT2AMYC
SCHEMBL13761761 0.90 KDM4E (0.50) L3MBTL1KDM4EATMKMT2AMYC
SCHEMBL13761758 0.90 KDM4E (0.50) L3MBTL1KDM4EATMKMT2AMYC
SCHEMBL13761770 0.90 KDM4E (0.50) L3MBTL1KDM4EATMKMT2AMYC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8845926-B2 Composition, method for manufacturing thin film, and method for manufacturing light-emitting element SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-09-30 US disclosed
US-8845926-B2 Composition, method for manufacturing thin film, and method for manufacturing light-emitting element SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-09-30 US disclosed
US-8518492-B2 Composition, method for manufacturing thin film, and method for manufacturing light-emitting element SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2013-08-27 US disclosed
US-8518492-B2 Composition, method for manufacturing thin film, and method for manufacturing light-emitting element SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2013-08-27 US disclosed
US-20130005067-A1 Anthracene Derivative, Material For Light Emitting Element, Light Emitting Element, Light Emitting Device, And Electronic Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2013-01-03 US disclosed
US-20130005067-A1 Anthracene Derivative, Material For Light Emitting Element, Light Emitting Element, Light Emitting Device, And Electronic Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2013-01-03 US disclosed
US-20120288620-A1 Composition, Method for Manufacturing Thin Film, and Method for Manufacturing Light-Emitting Element SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-11-15 US disclosed
US-20120288620-A1 Composition, Method for Manufacturing Thin Film, and Method for Manufacturing Light-Emitting Element SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-11-15 US disclosed
US-8298687-B2 Anthracene derivative, material for light emitting element, light emitting element, light emitting device, and electronic device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-10-30 US disclosed
US-8298687-B2 Anthracene derivative, material for light emitting element, light emitting element, light emitting device, and electronic device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-10-30 US disclosed
US-8039122-B2 Anthracene derivative, material for light emitting element, light emitting element, light emitting device, and electronic device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2011-10-18 US disclosed
US-8039122-B2 Anthracene derivative, material for light emitting element, light emitting element, light emitting device, and electronic device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2011-10-18 US disclosed
US-20110050118-A1 METHOD FOR SYNTHESIZING ANTHRACENE DERIVATIVE AND ANTHRACENE DERIVATIVE, LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, ELECTRONIC DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2011-03-03 US disclosed
US-20110050118-A1 METHOD FOR SYNTHESIZING ANTHRACENE DERIVATIVE AND ANTHRACENE DERIVATIVE, LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, ELECTRONIC DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2011-03-03 US disclosed
US-20090317539-A1 Composition, Method for Manufacturing Thin Film, and Method for Manufacturing Light-Emitting Element SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2009-12-24 US disclosed
US-20090015140-A1 Anthracene Derivative, Material for Light Emitting Element, Light Emitting Element, Light Emitting Device, and Electronic Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2009-01-15 US disclosed
US-20090015140-A1 Anthracene Derivative, Material for Light Emitting Element, Light Emitting Element, Light Emitting Device, and Electronic Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2009-01-15 US disclosed
US-20080286445-A1 COMPOSITION, AND METHOD OF FABRICATING LIGHT-EMITTING ELEMENT SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2008-11-20 US disclosed
US-20080286445-A1 COMPOSITION, AND METHOD OF FABRICATING LIGHT-EMITTING ELEMENT SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2008-11-20 US disclosed
US-20080107918-A1 METHOD FOR SYNTHESIZING ANTHRACENE DERIVATIVE AND ANTHRACENE DERIVATIVE, LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, ELECTRONIC DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2008-05-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110050118-A1 METHOD FOR SYNTHESIZING ANTHRACENE DERIVATIVE AND ANTHRACENE DERIVATIVE, LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, ELECTRONIC DEVICE ALAD, CYP2C9, CYP1A1 L3MBTL1 3456/4885KDM4E 2175/4885ATM 527/4885
US-20080107918-A1 METHOD FOR SYNTHESIZING ANTHRACENE DERIVATIVE AND ANTHRACENE DERIVATIVE, LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, ELECTRONIC DEVICE ALAD, CYP2C9, CYP1A1 L3MBTL1 3456/4885KDM4E 2175/4885ATM 527/4885
US-20090015140-A1 Anthracene Derivative, Material for Light Emitting Element, Light Emitting Element, Light Emitting Device, and Electronic Device CRY1, CRY2, CYBA L3MBTL1 3184/4885KDM4E 2566/4885ATM 729/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.